Sundial Growers Inc. (SNDL) operates in the healthcare and consumer sectors within the cannabis and related products industry. The company is involved in the cultivation, processing and commercialization of cannabis for recreational use, as well as investment activities within the sector.

Its business model combines direct cannabis operations with investments in financial assets and industry-related companies.

Its main areas of activity include:

• Cannabis cultivation and production.
• Distribution of adult-use cannabis products.
• Operation of cannabis retail networks.
• Investments in cannabis companies and financial assets.
• Brand development and product portfolio management.

The company primarily operates in Canada, participating in the regulated cannabis market and maintaining indirect exposure to other regions through its investment activities.

Key factors influencing its business include cannabis regulation, pricing dynamics, supply and demand balance, competition, operating costs and broader macroeconomic conditions.

Shares of Sundial Growers Inc. trade on the Nasdaq under the ticker SNDL.

History and Development

Sundial Growers was founded in 2006 in Canada, initially focusing on cannabis cultivation and production.

Following the legalization of recreational cannabis in Canada in 2018, the company expanded its operations within the regulated market.

In 2019, Sundial completed its Initial Public Offering (IPO) on the Nasdaq, raising capital to support expansion and operational growth.

In recent years, the company has undergone strategic restructuring, shifting toward a more diversified model that includes financial investments and retail expansion.

Sundial has focused on improving operational efficiency, consolidating assets and adapting to a more competitive and regulated cannabis market.

Additional Information

Sundial Growers Inc. (United States) is listed on the Nasdaq and has a market capitalization of $348.24 million, with shareholders equity totaling $757.94 million.

The company employs approximately 394 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Sundial Growers Inc. reported $670.36 million in revenue, generating net income of $-15.63 million.

Key financial metrics include a P/E ratio of -22.28, a price-to-book (P/B) ratio of 0.46, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SNDL.